Literature DB >> 17181634

Early cutaneous gene transcription changes in adult atopic dermatitis and potential clinical implications.

Douglas A Plager1, Alexey A Leontovich, Susan A Henke, Mark D P Davis, Marian T McEvoy, Gabriel F Sciallis, Mark R Pittelkow.   

Abstract

Atopic dermatitis (AD) is a common pruritic dermatitis with macroscopically non-lesional skin that is often abnormal. Therefore, we used high-density oligonucleotide arrays to identify cutaneous gene transcription changes associated with early AD inflammation as potential disease control targets. Skin biopsy specimens analysed included normal skin from five healthy non-atopic adults and both minimally lesional skin and nearby or contralateral non-lesional skin from six adult AD patients. Data were analysed on an individual gene basis and to identify biologically relevant gene networks. Transcription levels of selected genes were also analysed by quantitative PCR. Differential transcription occurring early in AD skin was indicated for (i) individual genes such as C-C chemokine ligand (CCL)18, CCL13, and interferon-alpha2 (IFNalpha2), (ii) genes associated with peroxisome proliferator-activated receptor (PPAR)alpha- and PPARgamma-regulated transcription, and possibly for (iii) immunoglobulin J-chain and heavy chain isotype transcripts. These data suggest that local changes in immunoglobulin-associated transcription may favour IgE over secretory immunoglobulin (multimeric IgM and IgA) expression in AD skin. Decreased PPAR activity appears common to both AD and psoriasis, and reduced cutaneous IFNalpha2 transcription also appears characteristic of AD. Identification of these genes and pathways will direct future research towards controlling AD.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17181634     DOI: 10.1111/j.1600-0625.2006.00504.x

Source DB:  PubMed          Journal:  Exp Dermatol        ISSN: 0906-6705            Impact factor:   3.960


  27 in total

1.  PPAR-alpha in cutaneous inflammation.

Authors:  Sandrine Dubrac; Matthias Schmuth
Journal:  Dermatoendocrinol       Date:  2011-01

2.  Gene transcription abnormalities in canine atopic dermatitis and related human eosinophilic allergic diseases.

Authors:  Douglas A Plager; Sheila M F Torres; Sandra N Koch; Hirohito Kita
Journal:  Vet Immunol Immunopathol       Date:  2012-06-12       Impact factor: 2.046

3.  Metformin ameliorates animal models of dermatitis.

Authors:  Soo Young Choi; Chanmi Lee; Min-Jeong Heo; Yeong Min Choi; In-Sook An; Seunghee Bae; Sungkwan An; Jin Hyuk Jung
Journal:  Inflammopharmacology       Date:  2020-04-28       Impact factor: 4.473

4.  Nonlesional atopic dermatitis skin is characterized by broad terminal differentiation defects and variable immune abnormalities.

Authors:  Mayte Suárez-Fariñas; Suzanne J Tintle; Avner Shemer; Andrea Chiricozzi; Kristine Nograles; Irma Cardinale; Shenghui Duan; Anne M Bowcock; James G Krueger; Emma Guttman-Yassky
Journal:  J Allergy Clin Immunol       Date:  2011-04       Impact factor: 10.793

5.  Multidimensional gene set analysis of genomic data.

Authors:  David Montaner; Joaquín Dopazo
Journal:  PLoS One       Date:  2010-04-27       Impact factor: 3.240

6.  Gene transcription changes in asthmatic chronic rhinosinusitis with nasal polyps and comparison to those in atopic dermatitis.

Authors:  Douglas A Plager; Jane C Kahl; Yan W Asmann; Allan E Nilson; John F Pallanch; Oren Friedman; Hirohito Kita
Journal:  PLoS One       Date:  2010-07-06       Impact factor: 3.240

Review 7.  Lipid disturbances in psoriasis: an update.

Authors:  Aldona Pietrzak; Anna Michalak-Stoma; Grazyna Chodorowska; Jacek C Szepietowski
Journal:  Mediators Inflamm       Date:  2010-07-20       Impact factor: 4.711

Review 8.  Post-genomics and skin inflammation.

Authors:  Daniela Braconi; Giulia Bernardini; Annalisa Santucci
Journal:  Mediators Inflamm       Date:  2010-09-19       Impact factor: 4.711

9.  Guanine nucleotide exchange factor RABGEF1 regulates keratinocyte-intrinsic signaling to maintain skin homeostasis.

Authors:  Thomas Marichal; Nicolas Gaudenzio; Sophie El Abbas; Riccardo Sibilano; Oliwia Zurek; Philipp Starkl; Laurent L Reber; Dimitri Pirottin; Jinah Kim; Pierre Chambon; Axel Roers; Nadine Antoine; Yuko Kawakami; Toshiaki Kawakami; Fabrice Bureau; See-Ying Tam; Mindy Tsai; Stephen J Galli
Journal:  J Clin Invest       Date:  2016-11-07       Impact factor: 14.808

10.  Cutaneous innate immune tolerance is mediated by epigenetic control of MAP2K3 by HDAC8/9.

Authors:  Yu Sawada; Teruaki Nakatsuji; Tatsuya Dokoshi; Nikhil Nitin Kulkarni; Marc C Liggins; George Sen; Richard L Gallo
Journal:  Sci Immunol       Date:  2021-05-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.